{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260608037260/en/Seaport-Therapeutics-Reports-Positive-Multiple-Ascending-Dose-Data-from-Phase-1-Proof-of-Concept-Trial-of-GlyphAgo%E2%84%A2-in-Healthy-Volunteers", "message": "News view counter 785721 successfully enlarged"}